CRISPR Can Help The Switch To Sustainable Cosmetics
The cosmetics industry is looking for greener ingredients as consumers demand more sustainable products. According…
The gene-editing tool CRISPR-Cas9 has taken over the life sciences world since its development in 2012. CRISPR has changed the way biology research is done, simplifying and speeding up the study of diseases and the discovery of drugs, as well as having a huge impact on crop and food development. Among all its possible applications, the fact that CRISPR can be used to tweak the human genome has made it especially promising for previously difficult-to-treat diseases.
But how does CRISPR work? What kind of therapies are being developed? How is the genome-editing market evolving? And how are stakeholders navigating the complex intellectual property around this technology? Find out the answers to these questions and more on this page.
The Genome Editing Toolbox: ZFNS, TALENS, and CRISPR in Biomedicine
This report covers the industry’s most common genome-editing tools, like CRISPR-Cas9, provides exclusive insights by experts, looks at the market, and addresses future applications and challenges of genome-editing tools.
Go to ReportThe cosmetics industry is looking for greener ingredients as consumers demand more sustainable products. According…
Phytoform, a London- and Boston-based startup, has received a €5M ($5.7M) investment to develop gene-edited…
CRISPR-Cas9 has taken the world by storm with the promise of making gene editing much…
Confidence in gene-edited T cell therapies from donor cells has faltered as Allogene Therapeutics paused…
CRISPR technology offers the promise to cure any human genetic disease with gene editing; which…
Last month, the US firm bluebird bio abandoned the sale of its gene therapy Zynteglo…
Tony Ho, Head of Research and Development at CRISPR Therapeutics, offers his insights into the…
The prevalence of neurological diseases has increased rapidly, and they are now the second biggest…
As next-generation gene-editing technologies become increasingly popular, biotech industry stakeholders carry the responsibility to ensure…
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
The controversial decision by the European courts in 2018 to regulate gene-edited organisms as GMOs…
The biotech community is raving about the long-anticipated recognition of the groundbreaking CRISPR-Cas9 gene editing…